E-cigarettes Contain Multiple Carcinogens
By HospiMedica International staff writers Posted on 10 Dec 2014 |
Image: Inside an Electronic cigarette (Photo courtesy of Blu e-cigarette).
A new study reveals that e-cigarettes can contain up to 10 times the level of cancer-causing agents than regular tobacco, including formaldehyde and acetaldehyde.
Researchers at the at Japanese National Institute of Public Health (Saitama, Japan) analyzed 13 cartridges of e-cigarette fluid using a smoking machine that "inhaled" 10 sets of 15 puffs. A range of hazardous compounds were found in the e-cigarettes, particularly carbonyl compounds such as formaldehyde, acetaldehyde, acetone, acrolein, propanal, crotonaldehyde, butanal, glyoxal, and methylglyoxal. The carbonyl compounds are generated by the vaporization of the e-liquid when it contacts with the heated nickel-chromium (nichrome) atomizer.
The researchers found that the results of the smoking machine tests varied, depending on the type of e-liquid in the cartridge, the compositions and concentrations of the compounds, and the battery voltage of the atomizer. One brand, the name of which was not revealed, showed a more than 10-fold level of formaldehyde on 9 out of every 10 sets. Another brand showed similar levels on several sets, but was not consistently that high. The study was published on October 28, 2014, in the International Journal of Environmental Research and Public Health.
“Very high amounts of formaldehyde were measured. Glyoxal and methylglyoxal, which show mutagenicity, are specific to e-cigarette aerosols and have been minimally detected in the mainstream smoke from traditional cigarettes,” concluded senior author Prof. Naoki Kunugita, MD, PhD, and colleagues. “The amount of carbonyl compounds in these brands of e-cigarettes varied significantly not only among different brands but also among different samples of the same products. However, in most cases, the levels are lower than those in tobacco cigarette smoke.”
Nicotine e-cigarettes, or electronic nicotine delivery systems (ENDS), were first developed by Herbert A. Gilbert, who patented a device described as “a smokeless non-tobacco cigarette” that involved “replacing burning tobacco and paper with heated, moist, flavored air” in 1963. However, the invention of the modern e-cigarette in 2003 is attributed to Hon Lik, a Chinese pharmacist, who introduced them to the Chinese market as a smoking cessation device in 2004.
Related Links:
Japanese National Institute of Public Health
Researchers at the at Japanese National Institute of Public Health (Saitama, Japan) analyzed 13 cartridges of e-cigarette fluid using a smoking machine that "inhaled" 10 sets of 15 puffs. A range of hazardous compounds were found in the e-cigarettes, particularly carbonyl compounds such as formaldehyde, acetaldehyde, acetone, acrolein, propanal, crotonaldehyde, butanal, glyoxal, and methylglyoxal. The carbonyl compounds are generated by the vaporization of the e-liquid when it contacts with the heated nickel-chromium (nichrome) atomizer.
The researchers found that the results of the smoking machine tests varied, depending on the type of e-liquid in the cartridge, the compositions and concentrations of the compounds, and the battery voltage of the atomizer. One brand, the name of which was not revealed, showed a more than 10-fold level of formaldehyde on 9 out of every 10 sets. Another brand showed similar levels on several sets, but was not consistently that high. The study was published on October 28, 2014, in the International Journal of Environmental Research and Public Health.
“Very high amounts of formaldehyde were measured. Glyoxal and methylglyoxal, which show mutagenicity, are specific to e-cigarette aerosols and have been minimally detected in the mainstream smoke from traditional cigarettes,” concluded senior author Prof. Naoki Kunugita, MD, PhD, and colleagues. “The amount of carbonyl compounds in these brands of e-cigarettes varied significantly not only among different brands but also among different samples of the same products. However, in most cases, the levels are lower than those in tobacco cigarette smoke.”
Nicotine e-cigarettes, or electronic nicotine delivery systems (ENDS), were first developed by Herbert A. Gilbert, who patented a device described as “a smokeless non-tobacco cigarette” that involved “replacing burning tobacco and paper with heated, moist, flavored air” in 1963. However, the invention of the modern e-cigarette in 2003 is attributed to Hon Lik, a Chinese pharmacist, who introduced them to the Chinese market as a smoking cessation device in 2004.
Related Links:
Japanese National Institute of Public Health
Latest Critical Care News
- Powerful AI Risk Assessment Tool Predicts Outcomes in Heart Failure Patients
- Peptide-Based Hydrogels Repair Damaged Organs and Tissues On-The-Spot
- One-Hour Endoscopic Procedure Could Eliminate Need for Insulin for Type 2 Diabetes
- AI Can Prioritize Emergecny Department Patients Requiring Urgent Treatment
- AI to Improve Diagnosis of Atrial Fibrillation
- Stretchable Microneedles to Help In Accurate Tracking of Abnormalities and Identifying Rapid Treatment
- Machine Learning Tool Identifies Rare, Undiagnosed Immune Disorders from Patient EHRs
- On-Skin Wearable Bioelectronic Device Paves Way for Intelligent Implants
- First-Of-Its-Kind Dissolvable Stent to Improve Outcomes for Patients with Severe PAD
- AI Brain-Age Estimation Technology Uses EEG Scans to Screen for Degenerative Diseases
- Wheeze-Counting Wearable Device Monitors Patient's Breathing In Real Time
- Wearable Multiplex Biosensors Could Revolutionize COPD Management
- New Low-Energy Defibrillation Method Controls Cardiac Arrhythmias
- New Machine Learning Models Help Predict Heart Disease Risk in Women
- Deep-Learning Model Predicts Arrhythmia 30 Minutes before Onset
- Breakthrough Technology Combines Detection and Treatment of Nerve-Related Disorders in Single Procedure